SOLID BIOSCIENCES INC (SLDB)
US83422E2046 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to SLDB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.34. This target is 69.5% above the current price.
SLDB was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SLDB.
In the last month the buy percentage rose by 6 points. So the trust of analysts is improving.
SLDB was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-28 | William Blair | Initiate | Outperform |
| 2024-03-18 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-15 | Citigroup | Initiate | Buy |
| 2024-03-14 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-11-11 | Barclays | Maintains | Overweight |
| 2022-11-11 | Piper Sandler | Maintains | Neutral |
| 2022-11-10 | SVB Leerink | Maintains | Market Perform |
| 2022-10-17 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-09-30 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2022-08-12 | Chardan Capital | Maintains | Buy |
| 2022-05-19 | Piper Sandler | Maintains | Neutral |
| 2022-04-28 | Chardan Capital | Maintains | Buy |
| 2022-04-28 | SVB Leerink | Maintains | Outperform |
| 2022-04-28 | Piper Sandler | Maintains | Neutral |
| 2021-09-24 | Chardan Capital | Maintains | Buy |
| 2021-07-12 | Piper Sandler | Initiate | Neutral |
| 2021-05-27 | Jefferies | Initiate | Buy |
| 2021-05-17 | Barclays | Maintains | Overweight |
| 2021-03-16 | Chardan Capital | Maintains | Buy |
| 2021-03-16 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-03-16 | Credit Suisse | Maintains | Neutral |
| 2021-03-09 | Barclays | Initiate | Overweight |